Lundbeck
Manufacturing · Denmark · 5,681 Employees
View Company Info for Free
About
Headquarters
9 Ottiliavej, Valby, Capital Region, 2500, Denm...Phone Number
+45 36301311Website
www.lundbeck.comRevenue
$3.1 BillionStock Symbol
HLBBFIndustry
Most Recent Scoops
Who is Lundbeck
Lundbeck Org Chart
Is Lundbeck your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Lundbeck launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Lundbeck
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Lundbeck, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Lundbeck has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Lundbeck has new funding data
Earning: See what the market has to say on Lundbeck recently announced quarterly report
Check out if Lundbeck is spiking on competitors!
Click to see if Lundbeck had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Lundbeck
Find more new buyers
Compare Similar Companies to Lundbeck
Compare insights from companies similar to Lundbeck, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Lundbeck
Lundbeck Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Lundbeck Tech Stack
A closer look at the technologies used by Lundbeck
Most Recent Scoops
Lundbeck News & Media
Lundbeck announces positive results from 12-month Open-Label Extension (OLE) of the PACIFIC trial evaluating bexicaserin in participants with Developmental and Epileptic Encephalopathies
Bexicaserin achieved an overall median seizure reduction of 59.3 percent in countable motor seizures over a 12-month open-label extension (OLE) treatment period. The treatment with bexicaserin demonstrated favorable safety and tolerability, with majority of participants completing the...JAMA Psychiatry Publishes Results of Otsuka and Lundbeck's Phase 3 Trial of Brexpiprazole in Combination with Sertraline in Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Lundbeck LLC (Lundbeck) today announced that the full results of a Phase 3 trial of brexpiprazole in combination with sertraline for the treatment of PTSD in adults have been published in JAMA Psychiatry. The results showed that in adults with PTSD, treatment with brexpiprazole in combination with sertraline resulted in statistically significant greater improvement of PLundbeck highlights commitment to the rare epilepsy community at American Epilepsy Society (AES) Annual Meeting with data presentations
Longboard Pharmaceuticals, now a wholly owned subsidiary of Lundbeck, presents scientific data in multiple poster presentations showcasing the potential of bexicaserin in Developmental and Epileptic Encephalopathies (DEEs) at the American Epilepsy Society (AES) Annual Meeting in Los Angeles, U.S. H. Lundbeck A/S (Lundbeck) today announced that data will be presented for bexicaserin, a novel, highly selective investigational potential treatment in development for seizures associated with DevelopmLundbeck announces expiration of Longboard tender offer and that all tender offer conditions are fulfilled
· A significant step forward in Lundbeck’s Focused Innovator strategy and advancing the goal of building a robust neuro-rare franchise · The transaction is expected to close on December 2, 2024, following Lundbeck’s acceptance of all shares of common stock validly tendered and not validly withdrawn pursuant to the tender offer · Total transaction value of approximately USD 2.6 billion equity value and USD 2.5 billion net of cash (approximately DKK 17 billion) · The
Frequently Asked Questions Regarding Lundbeck
Lundbeck, founded in 1915 and headquartered in Valby Denmark, is an international pharmaceutical company that researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders.... Read More